Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zocor, the postmarketing experience.

A J Smart1, L Walters, A D Marais

  • 1Department of Pharmacology, University of Cape Town.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LDL-cholesterol targets and lipid-lowering therapies - a plea to medical schemes and the Council for Medical Schemes.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same author

Response to: Prescribed Minimum Benefits complaints: A 5-year retrospective review.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

A convenient and versatile culturomics platform to expand the human gut culturome of Lachnospiraceae and Oscillospiraceae.

Beneficial microbes·2024
Same author

Management of hyperlipidaemia.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Premature cardiovascular deaths.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
Same author

[An abnormal lipid profile: when to perform additional research for a genetic cause?]

Nederlands tijdschrift voor geneeskunde·2023
Same journal

SAMA Health Summit Abstracts.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

On behalf of the South African Medical Association (SAMA), The Scientific Committee of the SAMA Health Summit, is pleased to pesent this abstract issue, showcasing the posters and oral presentations delivered at the Summit, which was held from 22-24 May 2026.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

Proceedings of the 2<sup>nd</sup> Data Driven Surgery Conference (DDSC 2025).

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

Clinical practice guidelines for the management of fever and neutropenia in South African children and adolescents with cancer.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

The changing fortunes of the District Health System in SA (1994 - 2020): A retrospective review.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

Thomas Micheal Guntram Ignaz Rehle (1951 - 2025).

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
See all related articles

This study developed a drug surveillance method to assess new drug safety and effectiveness. Simvastatin (Zocor) showed effectiveness in lowering cholesterol with a safety profile consistent with prior trials.

Area of Science:

  • Pharmacovigilance
  • Clinical Pharmacology

Background:

  • Developing robust postmarketing surveillance methodologies is crucial for evaluating new drug safety and effectiveness.
  • Simvastatin, a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, was selected as the study drug.

Observation:

  • Data were gathered from 100 physicians across South Africa, achieving a 66% response rate and enrolling 438 patients.
  • Effectiveness was measured by the percentage decrease in total cholesterol levels.

Findings:

  • Simvastatin demonstrated significant cholesterol reduction: 20.5% for patients on 10 mg daily and 27.6% for those escalated to 20 mg/d.
  • The drug's safety profile aligned with premarketing data, with non-compliance appearing dose-dependent.

Implications:

Related Experiment Videos

  • The developed surveillance methodology proved effective for collecting postmarketing safety and effectiveness data.
  • Simvastatin is confirmed as an effective treatment with a favorable safety profile in real-world settings.